195 related articles for article (PubMed ID: 15951837)
1. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates.
Bashuda H; Kimikawa M; Seino K; Kato Y; Ono F; Shimizu A; Yagita H; Teraoka S; Okumura K
J Clin Invest; 2005 Jul; 115(7):1896-902. PubMed ID: 15951837
[TBL] [Abstract][Full Text] [Related]
2. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
3. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
4. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
7. Anergic lymphocytes generated by blocking CD28 and ICOS pathways in vitro prolong rat cardiac graft survival.
Hara Y; Kitazawa Y; Funeshima N; Kawasaki M; Sato Y; Tezuka K; Kimura H; Hatakeyama K; Li XK
Int Immunopharmacol; 2006 Jul; 6(7):1143-51. PubMed ID: 16714218
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of renal allograft survival by anergic cells: advantages and limitations.
Bashuda H; Shimizu A; Uchiyama M; Okumura K
Clin Transplant; 2010 Jul; 24 Suppl 22():6-10. PubMed ID: 20590686
[TBL] [Abstract][Full Text] [Related]
9. Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4
Ezzelarab MB; Lu L; Shufesky WF; Morelli AE; Thomson AW
Front Immunol; 2018; 9():250. PubMed ID: 29520267
[TBL] [Abstract][Full Text] [Related]
10. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
[TBL] [Abstract][Full Text] [Related]
11. Adoptive transfer of regulatory T cells following chronic allograft rejection induces tolerance for secondary allografts.
Schmidt H; Filantenkov A; Reutzel-Selke A; Seifert M; Doebis C; Jurisch A; Pratschke J; Neuhaus P; Tullius SG; Volk HD
Transplant Proc; 2002 Nov; 34(7):2893-4. PubMed ID: 12431648
[No Abstract] [Full Text] [Related]
12. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
[TBL] [Abstract][Full Text] [Related]
13. Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.
Hotta K; Oura T; Dehnadi A; Boskovic S; Matsunami M; Rosales I; Smith RN; Colvin RB; Cosimi AB; Kawai T
Transplantation; 2018 Apr; 102(4):e128-e136. PubMed ID: 29300231
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
16. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
[TBL] [Abstract][Full Text] [Related]
18. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
19. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
20. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
